Accelsiors — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Accelsiors is a Hungary-based, full-service global CRO with over 22 years of experience, specializing in supporting emerging biotech companies. It offers end-to-end clinical trial services, consulting, and functional service provider (FSP) solutions across a wide range of therapeutic areas. The company differentiates itself through its proprietary Accelerant™ Penta-Helix platform, which integrates quality-by-design, scientific integrity, efficiency, data intelligence, and patient engagement into trial execution. With a global team operating in over 40 countries, Accelsiors combines worldwide reach with local expertise to streamline drug development.

OncologyCell and Gene TherapyVaccinesEndocrinologyAutoimmune DisordersInfectious DiseasesNervous SystemOrphan DisordersHepatology and GastrointestinalRespiratoryNephrologyWomen's HealthBiosimilarsGenericsPediatricMicrobiome

Technology Platform

Accelerant™ Penta-Helix Solutions: A proprietary framework integrating five core strands (QualityDRIVE™ for precision/quality-by-design, StrongCORE Scientific™ for scientific integrity, AcceleROUTE™ for operational efficiency, WideSCOPE Intelligence™ for integrated data systems, and ProPATIENT Solutions™ for patient engagement) to precision-engineer clinical trials.

Opportunities

The growing trend of outsourcing by emerging biotech companies, which lack large internal teams, provides a core market.

Increasing complexity of trials (e.g., in cell/gene therapy) and the need for integrated, technology-driven solutions play to Accelsiors' stated strengths in its Accelerant™ platform.

Risk Factors

Faces intense competition from large global CROs and other niche players.

Revenue is dependent on the funding health and R&D spending cycles of its emerging biotech client base, which can be volatile.

Operational risks include potential failures in trial execution, data management, or regulatory compliance.

Competitive Landscape

Operates in the highly competitive global CRO market, competing against large, full-service players like IQVIA, Labcorp, and ICON, as well as many mid-sized and specialized CROs. Its differentiation is its focus on emerging biotech and its proprietary Accelerant™ Penta-Helix operational platform.

More companies in Digital Health & Biotech SaaS →More companies in Hungary →